Immunomodulatory Effect of Probiotics on the Immunogenicity of Anti-SARS-CoV-2 Vaccines
Clinical trial NCT07610512 · COMPLETED
Trial details
- NCT number
- NCT07610512
- Sponsor
- Grape King Bio Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-13
- Primary completion
- 2022-03-31
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.